Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2017, Article ID 6087135, 6 pages
https://doi.org/10.1155/2017/6087135
Case Report

Atypical Complications of Graves’ Disease: A Case Report and Literature Review

1Endocrine Department, Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar
2Emergency Department, Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar

Correspondence should be addressed to Khaled Ahmed Baagar; aq.damah@ragaabk

Received 14 December 2016; Accepted 13 February 2017; Published 28 February 2017

Academic Editor: Toshihiro Kita

Copyright © 2017 Khaled Ahmed Baagar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. N. Rafhati, C. K. See, F. K. Hoo, and L. B. Badrulnizam, “A report of three cases of untreated Graves' disease associated with pancytopenia in Malaysia,” Electronic Physician, vol. 6, no. 3, pp. 877–882, 2014. View at Google Scholar
  2. M. O. Hegazi and S. Ahmed, “Atypical clinical manifestations of Graves' disease: an analysis in depth,” Journal of Thyroid Research, vol. 2012, Article ID 768019, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Franklyn and K. Boelaert, “Thyrotoxicosis,” The Lancet, vol. 379, no. 9821, pp. 1155–1166, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Garcia, L. D. França, V. Ellinger, and M. Wolff, “Marrow hypoplasia: a rare complication of untreated grave’s disease,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 58, no. 9, pp. 953–957, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. T. H. Kim, J. S. Yoon, B. S. Park et al., “A Case of pancytopenia with hyperthyroidism,” Yeungnam University Journal of Medicine, vol. 30, no. 1, pp. 47–50, 2013. View at Publisher · View at Google Scholar
  6. P. Naji, G. Kumar, S. Dewani, W. A. Diedrich, and A. Gupta, “Graves’ disease causing pancytopenia and autoimmune hemolytic anemia at different time intervals: a case report and a review of the literature,” Case Reports in Medicine, vol. 2013, Article ID 194542, 4 pages, 2013. View at Publisher · View at Google Scholar
  7. S. Raina, R. Kaul, and M. Mruthyunjaya, “Pancytopenia with cellular bone marrow related to Graves' hyperthyroidism,” Indian Journal of Endocrinology and Metabolism, vol. 16, no. 3, pp. 478–479, 2012. View at Publisher · View at Google Scholar
  8. C. S. P. Lima, D. E. Zantut Wittmann, V. Castro et al., “Pancytopenia in untreated patients with Graves' disease,” Thyroid, vol. 16, no. 4, pp. 403–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Kebapçilar, S. Yeşil, F. Bayraktar et al., “Recovery from pancytopaenia and liver dysfunction after administration of propylthiouracil for Graves' disease,” New Zealand Medical Journal, vol. 118, no. 1220, 2005. View at Google Scholar · View at Scopus
  10. P. Jha, Y. P. R. Singh, B. Ghimire, and B. K. U. Jha, “Pancytopenia in a surgical patient, a rare presentation of hyperthyroidism,” BMC surgery, vol. 14, article 108, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. W. J. Irvine, F. C. W. Wu, S. J. Urbaniak, and F. Toolis, “Peripheral blood leucocytes in thyrotoxicosis (Graves' disease) as studied by conventional light microscopy,” Clinical & Experimental Immunology, vol. 27, no. 2, pp. 216–221, 1977. View at Google Scholar · View at Scopus
  12. A. G. Gianoukakis, M. J. Leigh, P. Richards et al., “Characterization of the anaemia associated with Graves' disease,” Clinical Endocrinology, vol. 70, no. 5, pp. 781–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. Bahn, H. B. Burch, D. S. Cooper et al., “Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and American association of clinical endocrinoloigists,” Endocrine Practice, vol. 17, no. 3, pp. 456–520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. D. S. Cooper, “Antithyroid drugs,” The New England Journal of Medicine, vol. 352, no. 9, pp. 905–917, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Watanabe, H. Narimatsu, J. Y. Noh et al., “Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and pancytopenia involving 50,385 patients with Graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 1, pp. E49–E53, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Duquenne, D. Lakomsky, J. C. Humbert, S. Hadjadj, G. Weryha, and J. Leclere, “Resolutive pancytopenia with effective treatment of hyperthyroidism,” Presse Medicale, vol. 24, no. 17, pp. 807–810, 1995. View at Google Scholar · View at Scopus
  17. A. L. Talansky, P. Schulman, V. P. Vinciguerra, D. Margouleff, D. R. Budman, and T. J. Degnan, “Pancytopenia complicating Graves’ disease and drug-induced hypothyroidism,” Archives of Internal Medicine, vol. 141, no. 4, pp. 544–545, 1981. View at Publisher · View at Google Scholar · View at Scopus
  18. M. O. Hegazi and M. R. El-Sonbaty, “Unusual presentations of hyperthyroidism,” in Handbook of Hyperthyroidism: Etiology, Diagnosis and Treatment, L. Mertens and J. Bogaert, Eds., pp. 265–270, Nova Science Publishers, 2010. View at Google Scholar
  19. R. Malik and H. Hodgson, “The relationship between the thyroid gland and the liver,” The Quarterly Journal of Medicine, vol. 95, pp. 559–569, 2002. View at Google Scholar
  20. V. Sarinnapakorn, P. Noppavetchwich, T. Sunthorntepwarakul, C. Deerochanawong, and S. Ngongamrut, “Abnormal liver function test in Graves' disease: a prospective study of comparison between the hyperthyroid state and the euthyroid state,” Journal of the Medical Association of Thailand, vol. 94, supplement 2, pp. S11–S16, 2011. View at Google Scholar · View at Scopus
  21. G. R. Doran, “Serum enzyme disturbances in thyrotoxicosis and myxoedema,” Journal of the Royal Society of Medicine, vol. 71, no. 3, pp. 189–194, 1978. View at Google Scholar · View at Scopus
  22. M. Biscoveanu and S. Hasinski, “Abnormal results of liver function tests in patients with Graves' disease,” Endocrine Practice, vol. 6, no. 5, pp. 367–369, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Khemichian and T.-L. Fong, “Hepatic dysfunction in hyperthyroidism,” Gastroenterology & Hepatology, vol. 7, no. 5, pp. 337–339, 2011. View at Google Scholar · View at Scopus
  24. D. S. Cooper, “Hyperthyroidism,” The Lancet, vol. 362, no. 9382, pp. 459–468, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. J. D. Myers, E. S. Brannon, and B. C. Holland, “A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism,” The Journal of Clinical Investigation, vol. 29, no. 8, pp. 1069–1077, 1950. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Marvisi, P. Zambrelli, M. Brianti, G. Civardi, R. Lampugnani, and R. Delsignore, “Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy,” European Journal of Internal Medicine, vol. 17, no. 4, pp. 267–271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Muthukumar, D. Sadacharan, K. Ravikumar, G. Mohanapriya, Z. Hussain, and R. V. Suresh, “A prospective study on cardiovascular dysfunction in patients with hyperthyroidism and its reversal after surgical cure,” World Journal of Surgery, vol. 40, no. 3, pp. 622–628, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Sugiura, S. Yamanaka, H. Takeuchi, N. Morimoto, M. Kamioka, and Y. Matsumura, “Autoimmunity and pulmonary hypertension in patients with Graves’ disease,” Heart and Vessels, vol. 30, no. 5, pp. 642–646, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Armigliato, R. Paolini, S. Aggio et al., “Hyperthyroidism as a cause of pulmonary arterial hypertension: a prospective study,” Angiology, vol. 57, no. 5, pp. 600–606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. I. A. Nakchbandi, J. A. Wirth, and S. E. Inzucchi, “Pulmonary hypertension caused by Graves' thyrotoxicosis: normal pulmonary hemodynamics restored by 131I treatment,” Chest, vol. 116, no. 5, pp. 1483–1485, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. M. O. Hegazi, A. El Sayed, and H. El Ghoussein, “Pulmonary hypertension responding to hyperthyroidism treatment,” Respirology, vol. 13, no. 6, pp. 923–925, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Frogoudaki, A. S. Triantafyllis, E. Vassilatou, C. Tsamakis, A. Zacharoulis, and J. Lekakis, “Shortness of breath and lower limb edema in a 54-year-old woman, is there any cure?” Research in Cardiovascular Medicine, vol. 5, no. 1, Article ID e30549, 2015. View at Publisher · View at Google Scholar
  33. B. Biondi and G. J. Kahaly, “Cardiovascular involvement in patients with different causes of hyperthyroidism,” Nature Reviews Endocrinology, vol. 6, no. 8, pp. 431–443, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Vargas, A. Fernandez-Rivas, and A. Osuna, “Effects of methimazole in the early and established phases of NG-nitro-l-arginine methyl ester hypertension,” European Journal of Endocrinology, vol. 135, no. 4, pp. 506–513, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Y. Hwang, S. H. Bae, J. M. Lee et al., “A case of pulmonary arterial hypertension associated with hyperthyroidism, persistent after euthyroidism was obtained,” Korean Circulation Journal, vol. 40, no. 11, pp. 593–595, 2010. View at Publisher · View at Google Scholar · View at Scopus